normal

Ljubimova JY, Holler E, Black KL, Ljubimov AV. Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions. Nanomedicine (Lond). 2024[...]

By sjmartinez • August 8, 2024